About Kheiron Med
Kheiron Med is a Healthcare company based in London (United Kingdom) founded in 2016, and was acquired by DeepHealth in October 2024. AI platform to assist radiologists in analyzing mammography X ray images for breast cancer screening. It operates in the Healthcare and Technology sectors. Kheiron Med has raised $30.93 million across 10 funding rounds from investors including DeepHealth, Exor and European Union. Kheiron Med was last valued at $69.4 million in August 2020. Its focus areas include HealthTech, Clinical Labs IT, Radiology and Image Analysis. Its legal entity is KHEIRON MEDICAL TECHNOLOGIES LTD. Its competitors include Perspectum and IXICO; 1 of its 2 listed competitors has raised funding.
Company details
Kheiron Med was established in 2016 in London, United Kingdom, within the healthcare technology sector. An AI platform is offered to support radiologists, radiology departments, imaging centers, and hospitals in evaluating mammography X-ray images for breast cancer detection. Machine learning is applied to build image analysis tools that help maintain reporting accuracy. The product Mia is integrated to facilitate decision-making in radiological assessments, operating via the domain kheironmed.com.
- Headquarters London, United Kingdom
- Stage Acquired
- SectorsHealthcareTechnology
- Emailβ’β’β’β’β’β’β’β’
- Website kheironmed.com
- Social LinkedIn X YouTube
- Acquired by DeepHealth (Oct 2024)
- Legal Name Kheiron Medical Technologies Ltd
- Date of Incorporation 17 May, 2016
- Jurisdiction LONDON, ENGLAND
- Total Equity Funding$30.93M (USD)
in 10 rounds
- InvestorsDeepHealth
& 11 more
- Acquired byDeepHealth
(Oct 2024)
Apps and channels of Kheiron Med
its YouTube channel Kheiron Medical has 131 subscribers and 17 videos.
Videos from Kheiron Med
The most watched videos on Kheiron Med's YouTube channel, Kheiron Medical (131 subscribers). Click a video to play it here.
More on Kheiron Medical.
Funding Insights of Kheiron Med
Kheiron Med has successfully raised a total of $30.93M across 10 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $30.93M
- Total Rounds 10
- First Round $28,400
(Jun 2016)
- Investors Count 11
All 10 funding rounds of Kheiron Med with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2020 | Debt – Conventional | $69.4M | β | ||
| Aug 2019 | $23.8M | Series A | $63.9M | Atomico | |
| Apr 2019 | $55,824 | Grant | β | β | |
| Jan 2019 | $56,078 | Grant | β | β | |
| Nov 2018 | Grant | β | β | β | |
| Aug 2018 | $4.1M | Series A | $β’β’β’β’β’ | β | β |
| Apr 2018 | Seed | β | 7percent Ventures | β | |
| Jun 2017 | Seed | β | Entrepreneur First, Connect Ventures | β | |
| Mar 2017 | $3M | Seed | β | β | |
| Jun 2016 | $28,400 | Seed | $β’β’β’β’β’ | β | β |
| Date | Valuation | Stage |
|---|---|---|
| Aug 2020 | $69.4M | β’β’β’β’β’β’β’β’ |
| Aug 2019 | $63.9M | β’β’β’β’β’β’β’β’ |
| Aug 2018 | $β’β’β’β’β’ | β’β’β’β’β’β’β’β’ |
Full valuation and stage history of Kheiron Med
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $69.4M (Aug 2020). 12 investors in total: 12 institutional.
Investors in Kheiron Med
Kheiron Med has secured backing from 12 investors, including institutional and venture fund investors. Prominent investors backing the company include DeepHealth, Exor and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Tech-based companies are invested in by Atomico venture capital fund. | 2006 | atomico.com | London, United Kingdom | |
Multiple sectors are targeted for venture capital investments by Greycroft. | greycroft.com | New York, United States | ||
VC and PE firm focused on seed and early stage tech companies | hoxtonventures.com | London, United Kingdom | ||
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
Provider of a program turning individuals into funded technology company founders | joinef.com | London, United Kingdom | ||
Early-stage investments are made in product-focused companies by Connect Ventures. | connectventures.co | London, United Kingdom | ||
Investments are made in pre-seed and seed-stage deep-tech startups. | 7pc.vc | London, United Kingdom | ||
Early-stage venture capital investments are made in innovative startups. | 7pc.co | London, England | ||
Venture capital firm focused on health insurance companies and operates multiple industries | 1927 | exor.com | Amsterdam, Netherlands | |
Strategy consulting services are provided by Connect Ventures. | connect-ventures.com | Bengaluru, India |
Investor details for Kheiron Med
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Kheiron Med
11 people are tracked at Kheiron Med (6 in leadership, 5 in team).
| Name | Role | Group |
|---|---|---|
Edith Karpati | Medical Product Director | Leadership |
Lucy Mack | Head of People | Leadership |
Karen Fitchett | VP, Products | Leadership |
Jonathan Levy | Head, Customer Success | Leadership |
Jonathan Bullock | Chief Operating Officer | Leadership |
Ilona Gaweda | Senior Director, Engineering | Leadership |
Barbara Csík | Office Manager | Team |
Dezso Visi | Regional Manager | Team |
Tom Bradberry | Global Commercial Operations Lead | Team |
Paweł Borkowski | Senior Software Engineer | Team |
Daniel Sullivan | Devops/infrastructure Lead | Team |
Complete people profiles for Kheiron Med
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Kheiron Med
5 dated milestones of Kheiron Med across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Kheiron Med is founded.
- Funding First funding round of $28K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Debt β Conventional,.
- Exit Acquired by DeepHealth.
Competitors of Kheiron Med
Kheiron Med has 2 listed competitors in our database, 1 of them funded. They include Perspectum and IXICO.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| perspectum.com | 2012 | Oxford, United Kingdom | $95.94M | 196 | Precision medicine software for liver disease diagnosis is offered. | |
| ixico.com | 2004 | London, United Kingdom | 93 | AI-based medical image management and analysis solutions for healthcare organizations |
Detailed competitors of Kheiron Med
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Kheiron Med
Websites that share an audience with Kheiron Med (kheironmed.com).
Websites whose visitors overlap most with Kheiron Med. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
radiologybusiness.com | radiologybusiness.com | 100% | #464,519 | β | |
| femtechinsider.com | 67% | #728,783 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Kheiron Med
Complete news archive for Kheiron Med
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kheiron Med
Kheiron Med was founded in 2016.
Kheiron Med is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Kheiron Med is a funded company, having raised a total of $30.93M across 10 funding rounds to date. The company's 1st funding round was a Seed of $28.4K, raised on Jun 2016.
Kheiron Med was established in 2016 in London, United Kingdom, within the healthcare technology sector. An AI platform is offered to support radiologists, radiology departments, imaging centers, and hospitals in evaluating mammography X-ray images for breast cancer detection. Machine learning is applied to build image analysis tools that help maintain reporting accuracy. The product Mia is integrated to facilitate decision-making in radiological assessments, operating via the domain kheironmed.com.
Kheiron Med's top competitors include Perspectum and IXICO.
Kheiron Med has 12 investors. Key investors include DeepHealth, Exor, European Union, Atomico, and 7percent Ventures.
The valuation of Kheiron Med is $69.4M as of Aug 2020.
Kheiron Med operates through Kheiron Medical Technologies Ltd.
Yes. Kheiron Med was acquired by DeepHealth in October 2024.

